Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06175312 · ClinicalTrials.gov registry record · NA
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)
A NA study of Attention and Basic Science: Visual Attention in Healthy Participants, sponsored by University of California, Santa Barbara.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06175312: Completed NA study of Attention and Basic Science: Visual Attention in Healthy Participants, sponsored by University of California, Santa Barbara.
NCT06175312 is a NA study of Attention and Basic Science: Visual Attention in Healthy Participants that has completed, run by University of California, Santa Barbara. The registered enrollment target is 10 participants, below the 96-participant average among 13 other Attention trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06175312, a NA study of Attention and Basic Science: Visual Attention in Healthy Participants, has completed, sponsored by University of California, Santa Barbara.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one needs to direct their attention to different locations. One prominent theory about how one accomplishes this claims that important locations are identified based on distinct feature types (for example, motion or color), with locations most unique compared to the background most likely to be attended. An important component of this theory is that individual feature dimensions (again, color or motion) are computed within their own 'feature maps', which are thought to be implemented in specific brain regions. However, whether and how specific brain regions contribute to these feature maps remains unknown. The goal of this study is to determine how brain regions that respond strongly to different feature types (color and motion) and which encode spatial locations of visual stimuli extract 'feature dimension maps' based on stimulus properties, including feature contrast. The investigators hypothesize that feature-selective brain regions act as neural feature dimension maps, and thus encode representations of salient location(s) based on their preferred feature dimension. The investigators will scan healthy human participants using functional MRI (fMRI) in a repeated-measures design while they view visual stimuli made salient based on different combinations of feature dimensions. The investigators will employ state-of-the-art multivariate analysis techniques that allow them to reconstruct an 'image' of the stimulus representation encoded by each brain region to dissect how neural tissue identifies salient locations. Each participant will perform a challenging task at the center of the screen to ensure they keep their eyes still and ignore the stimuli presented in the periphery, w
Primary Outcome
The investigators will use BOLD activation patterns measured from each retinotopic ROI to fit quantitative models of spatial encoding. These models will be used to reconstruct stimulus representations on experimental trials to quantify how stimulus representations are encoded in each brain region studied, and how these representations change across experimental manipulations. These measurements will be used to test the impact of stimulus manipulations on stimulus representations in different bra
Conditions Studied
Interventions
- OTHER Stimulus properties: salience-defining feature
- OTHER Stimulus properties: magnitude of salience
Study Locations (1)
California
- University of California, Santa Barbara - Santa Barbara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT06175312 record still lists
NCT06175312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 96-participant average among 13 other Attention trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with Attention appearing as the primary indexed condition, and to 2 interventions - of which Stimulus properties: salience-defining feature is the first listed.
NCT06175312 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06175312 about?
NCT06175312 is a clinical study titled "Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)". How does one know what to look at in a scene? Imagine a "Where's Waldo" game - it's challenging to find Waldo because there are many 'salient' locations in the picture, each vying for one's attention. One can only attend to a small location on the picture at a given moment, so to find Waldo, one nee...
What is the current status of trial NCT06175312?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-04-25. Estimated completion is 2025-01-31.
What conditions does trial NCT06175312 study?
This clinical trial studies the following conditions: Attention, Basic Science: Visual Attention in Healthy Participants, Basic Science: Neural Representations of Location.
What interventions are being tested in trial NCT06175312?
The interventions under investigation include: Stimulus properties: salience-defining feature (OTHER), Stimulus properties: magnitude of salience (OTHER).
Who is sponsoring clinical trial NCT06175312?
This trial is sponsored by University of California, Santa Barbara, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06175312 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06175312's enrollment target sits among peer trials
10 14th of 13 the lowest of 13 other Attention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans
RECRUITING · NA
-
Experiment 2: One Target in Many Situations
RECRUITING · NA
-
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
RECRUITING · NA
-
Mixed Vs Blocked Search: Four Unique Tasks
RECRUITING · NA
-
Experiment 3: Mixed vs Blocked; Dashboard Paradigm
RECRUITING · NA
-
EndeavorOTC® Research Study in College Students
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI